The analysis of lipid profiling in the prediction of risk of developing type 2 diabetes and cardiovascular diseases can aid in recommending lifestyle changes and diet before the development of the diseases.
Read More »Eating Habits and Their Impact on T2D Treatments
Studies have shown that emotional eating and other eating behaviors could reduce weight loss when taking GLP-1 receptor agonists.
Read More »Can Caffeine be the Key to Fighting CVD?
Studies have found that average levels of moderate caffeine intake are related to lower cardiovascular risk.
Read More »Treating CVD with DPP-4 Inhibitors vs. Sulphonylureas Plus Metformin
New retrospective study results compare the two most primarily prescribed antidiabetic medication classes in addition to metformin to determine the impact on the incidence of CV events in patients with T2DM.
Read More »Youth T2D Has Serious Consequences
According to the research presented by Dr. Petter Bjornstad from the University of Colorado Anschutz Medical Campus, the risk of microvascular complications increases by the time of young adulthood in patients who have diabetes in youth.
Read More »Can a Calorie-Restricted Diet Improve Long-Term Progressive Kidney Function Decline?
Studies have found that there may be a benefit in implementing a calorie-restricted diet in patients with type 2 diabetes to improve glomerular hyperfiltration.
Read More »The Safety and Efficacy of Next-Generation G7 CGM Over G6
The seventh-generation (G7) continuous glucose monitor provides accurate and safe glucose readings during 10.5 days of use among adults that have diabetes.
Read More »American Heart Association Reveals Comprehensive Guidance to Control the Risk of Heart Disease in T2D Patients
Data suggest that fewer than twenty percent of patients with type 2 diabetes are lowering their risk of heart disease, prompting prominent doctors to demand immediate action.
Read More »A1c, Sleep Quality and Duration in Prediabetes Patients
There is growing evidence suggesting that the quality and duration of sleep may contribute to the risk of prediabetes progressing to type 2 diabetes.
Read More »Insulin Abnormalities in Metabolic Syndrome and T2D
Insulin resistance presents a biomarker for poor metabolic health.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.